AZTA Azenta, Inc. Insider Trading

Director Cornog buys 10,000 AZTA shares at $16.38; stock down 57.7% from 52-week high, company unprofitable with -9.5% revenue growth

Director William L Cornog purchased 10,000 shares of Azenta at $16.38 on 2026-05-18, increasing his holdings from 9.7K to 19.7K shares (+103.1%). The purchase occurs amid significant headwinds: the stock has fallen 57.7% from its 52-week high of $41.73, declined 29.5% over the past 30 days, and the company posted a net loss of $-160.8M against quarterly revenue of $144.8M with annual revenue declining 9.5% year-over-year. Cornog's prior buy at AZTA in November 2024 was followed by a 90-day return of +14.7%, demonstrating a historical instance of profitable timing at this ticker. His cross-ticker buy history shows an average 90-day return of +9.1% across 6 prior trades.

CFO Lin Lawrence Y. buys 2,500 AZTA shares at $27.96 amid -47.7% decline from 52-week high and $-52.8M net loss.

Lin Lawrence Y., the CFO, purchased 2,500 shares at $27.96, increasing his holdings to 46,013 shares post-transaction. The company is currently unprofitable with a net loss of $-52.8M over its most recent full fiscal year, and the stock has declined 47.7% from its 52-week high of $55.89 while trading at $29.21 currently. The acquisition occurs within a context of significant financial pressure, where annual revenue has contracted by 1.3% year-over-year. As the chief financial officer responsible for the company's financial performance and capital allocation, his open-market purchase at a depressed price point warrants investor attention to the company's operational outlook and management's confidence in recovery prospects.

SVP Zhou Ginger purchased 417 AZTA shares at $45.88; holdings now 27.9K shares. Company unprofitable, revenue flat YoY.

Zhou Ginger, SVP and General Manager of Genom division, purchased 417 shares of Azenta at $45.88 on 2025-01-31, bringing her post-transaction holdings to 27.9K shares—a modest 1.5% increase. The company is currently unprofitable (full-year net income was negative) with flat annual revenue growth (-1.3% YoY), and the stock is trading $51.97 versus a 52-week high of $67.30, representing a decline of 22.8% from that peak. The purchase occurred at a price below the current market level, though it remains within the historical trading range and represents a relatively small absolute transaction of $19.1K. This modest buy by a mid-level executive in a challenged operating environment does not constitute a material confidence signal; investors should monitor whether other insiders exhibit similar activity or whether company fundamentals show signs of stabilization.

Director Hirsch Didier bought 1,000 shares of AZTA at $39.50 on 2024-11-18; 3 other insiders bought within 14 days as stock down -39.4% from 52-week high.

Didier's purchase of 1,000 shares (+40.6% increase to his 3.5K-share post-transaction holding) occurs as part of a broader cluster pattern: 3 other insiders also bought within the past 14 days. This coordinated insider buying activity is noteworthy given that Azenta is currently unprofitable (net income $-6.6M in its most recent full fiscal year) yet shows strong top-line momentum with annual revenue growth of +19.7%. The stock is trading at $40.91, down -39.4% from its 52-week high of $67.51, having declined -7.3% over the past 30 days and -17.2% over 90 days. Multiple insiders accumulating shares during a period of significant drawdown from highs and amid unprofitability warrants investor attention to the company's near-term trajectory and whether management views current valuations as attractive relative to growth prospects.

Director Madaus Martin D bought 4,940 shares of Azenta at $40.77 on 2024-11-19; 3 other insiders also bought within 14 days amid -39.4% drop from 52-week high.

Director Madaus Martin D purchased 4,940 shares for $201,403.80, increasing his holdings by 200.4%, while the stock has declined 39.4% from its 52-week high of $67.51 and 7.3% over the past 30 days. Notably, this transaction is part of a cluster pattern with 3 other insiders buying within the past 14 days, suggesting coordinated interest at depressed levels. The company is currently unprofitable with negative net income of $-6,582,000.00 in the latest quarter, yet maintains revenue of $172,809,000.00 and posted annual revenue growth of 19.7%, creating a mixed fundamental backdrop. The insider's cross-ticker track record shows 5 prior buys with a 100.00% 90-day win rate and an average 90-day return of +9.9%, though this prior success does not speak to timing or conviction at this specific ticker.

Director Cornog buys 12,500 AZTA shares at $39.60 ($495.0K); holdings surge 554.3%; cluster of 3 other insider buys in 14 days.

Director William L Cornog purchased 12,500 shares at $39.60, expanding his holdings from 2,255 to 14,755 shares—a 554.3% increase that represents a material accumulation by this insider. The transaction occurs as the stock trades 39.4% below its 52-week high of $67.51, and notably three other insiders bought within the past 14 days, establishing a cluster acquisition pattern. The company is currently unprofitable (net income of $-6.6M in the latest quarter) despite 19.7% annual revenue growth, placing this buy against mixed fundamentals. Cornog's cross-ticker track record shows 100% 90-day win rate with an average 90-day return of +17.6%, though this historical success across multiple tickers provides limited predictive weight for outcomes at this specific security.

CEO Marotta purchased 13,966 shares for $552,903.75 at AZTA as stock down 39.4% from 52-week high; cluster buy pattern with 3 other insiders in 14 days

John Marotta, President and CEO, executed 2 separate purchases totaling 13,966 shares for $552,903.75 on 2024-11-18 and 2024-11-19, increasing his holdings by 16.1% to 100,861 shares post-transaction. The purchases occurred at a blended average price of $39.59, while the stock currently trades at $40.91, down 39.4% from its 52-week high of $67.51 and declining 17.2% over the past 90 days. Notably, 3 other insiders also purchased shares within the same 14-day window, forming a cluster buy pattern. The company generated $172.8M in latest-quarter revenue with +19.7% annual growth, but reported negative net income of $-6.6M and was unprofitable over its most recent full fiscal year, creating a disconnect between revenue momentum and current profitability that warrants investor attention to near-term operational performance.